Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
-
Published:2024-03
Issue:
Volume:13
Page:100122
-
ISSN:2666-4593
-
Container-title:Brain Disorders
-
language:en
-
Short-container-title:Brain Disorders
Author:
Ben-Azu BennethORCID,
Adebayo Olusegun G.,
Fokoua Aliance R.,
Onuelu Jackson E.,
Asiwe Jerome N.,
Moke Emuesiri G.,
Omogbiya Itivere A.,
Okpara Oghenemarho L.,
Okoro Jennifer E.,
Oghenevwerutevwe Omadevuaye M.,
Uruaka Christian I.
Reference65 articles.
1. The global burden of schizophrenia and the impact of urbanization during 1990 –2019 : an analysis of the global burden of disease study 2019;Li;Environ. Res.,2023
2. Diagnostic and statistical manual of mental disorders;Del Barrio;Curated Ref. Collect. Neurosci. Biobehav. Psychol.,2016
3. Psychotic disorders, definition, sign and symptoms, antipsychotic drugs, mechanism of action, pharmacokinetics & pharmacodynamics with side effects & adverse drug reactions: updated systematic review article;Bangwal;J. Drug Deliv. Ther.,2020
4. Animal models of psychotic disorders : dimensional approach modeling negative symptoms;Kirby,2016
5. Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: evidence for the involvement of dopaminergic, seroton- ergic, and cholinergic systems;Chatterjee;Pharm. Biol.,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献